Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Prostate Adenocarcinoma × Gallium × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostate Adenocarcinoma 1

Interventions

niraparib 1 luprolide acetate gel depot 1 apalutamide 1 Triptorelin Pamoate 1 Receptors, Bombesin 1 Radiotherapy 1 Radiation Dose Hypofractionation 1 Radiation 1 Neoadjuvant Therapy 1 Methods 1 Magnetic Resonance Spectroscopy 1 Leuprolide 1 Goserelin 1 Gallium 1 Educational Status 1 Early Intervention, Educational 1 Counseling 1 BAY 86-7548 1 Adjuvants, Pharmaceutic 1 68Ga-bombesin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02624518 2023-04-10

68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer

Stanford University

Phase 2/3 Completed

122 enrolled 8 charts

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡